We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

40 hedge funds and large institutions have $246M invested in Vigil Neuroscience in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

8% more funds holding

Funds holding: 37 → 40 (+3)

0.08% more ownership

Funds ownership: 70.22% → 70.3% (+0.08%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

21% less capital invested

Capital invested by funds: $312M → $246M (-$66M)

Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.64%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
3
Increased
11
Reduced
10
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$802K
2
Morgan Stanley
Morgan Stanley
New York
+$554K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$352K
4
Jane Street
Jane Street
New York
+$306K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$210K

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$888K
2
Goldman Sachs
Goldman Sachs
New York
-$542K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$189K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$94.4K
5
Citigroup
Citigroup
New York
-$28.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$57.1M – – –
NV
2
Northpond Ventures
Maryland
$41.3M – – –
AG
3
Artal Group
Luxembourg
$22M – – –
Citadel Advisors
4
Citadel Advisors
Florida
$21.2M -$23.8K -2,120 -0.1%
DM
5
Deerfield Management
New York
$20.1M – – –
DTC
6
Deep Track Capital
Connecticut
$19.8M -$888K -79,037 -4%
BI
7
BVF Inc
California
$17.8M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.13M -$94.4K -8,400 -1%
CAM
9
Cormorant Asset Management
Massachusetts
$6.04M – – –
PBPIA
10
Pivotal bioVenture Partners Investment Advisor
California
$5.49M – – –
RSCM
11
Rock Springs Capital Management
Maryland
$4.62M – – –
O
12
OrbiMed
New York
$4.39M – – –
HMC
13
Harvard Management Company
Massachusetts
$2.83M – – –
TOCUITCONY
14
Trustees of Columbia University in the City of New York
New York
$1.89M – – –
LGM
15
Logos Global Management
California
$1.84M – – –
DCM
16
DAFNA Capital Management
California
$1.69M +$38.9K +3,462 +2%
LCM
17
Laurion Capital Management
New York
$1.27M – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.1M +$97K +8,625 +8%
Barclays
19
Barclays
United Kingdom
$1.02M -$18.5K -1,645 -2%
BlackRock
20
BlackRock
New York
$999K -$3.43K -305 -0.3%
Citigroup
21
Citigroup
New York
$895K -$28.4K -2,529 -3%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$849K +$832 +74 +0.1%
Millennium Management
23
Millennium Management
New York
$699K +$802K +71,381 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$575K +$352K +31,343 +114%
Morgan Stanley
25
Morgan Stanley
New York
$571K +$554K +49,252 +542%
1
2

VIGL Hedge Fund Activity: Q1 2023 in Review

40 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2023, worth a combined $246M — down 21% from $312M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VIGL positions and 0 closed out — a net gain of 3 holders — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $802K. The largest seller was Deep Track Capital, cutting an estimated $888K.

  • 40 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2023, up from 37 in Q4 2022.
  • Funds reported $246M of Vigil Neuroscience stock for Q1 2023, down 21% quarter-over-quarter.
  • 3 funds opened new Vigil Neuroscience positions in Q1 2023 and 0 closed out, a net change of +3 holders.
  • The largest Vigil Neuroscience buyer in Q1 2023 was Millennium Management, an estimated $802K added.
  • The largest Vigil Neuroscience seller in Q1 2023 was Deep Track Capital, an estimated $888K sold.

Based on aggregated 13F filings for Q1 2023.